Newstral
Article
thedailyrecord.com on 2015-07-21 19:56
Synthetic Biologics closes public offering
Related news
- Synthetic Biologics gets CDC contract for ribaxamase studythedailyrecord.com
- Synthetic Biologics posts bigger lossthedailyrecord.com
- Duos Technologies Group closes public offeringbizjournals.com
- MHeat Biologics suspends proposed common stock public offering the day after announcing itmarketwatch.com
- Public Bitcoin Miner Closes $172 Million Common Share Public Offeringbitcoinmagazine.com
- CItamar Medical closes Nasdaq public offering at $40.25 millioncalcalistech.com
- Silver Spring’s Aziyo Biologics officially goes publicbizjournals.com
- Heat Biologics prices offering; shares drop 65 percentbizjournals.com
- Laredo closes stock offeringjournalrecord.com
- RedHill closes $20M public offering to prep commercialization of new drugbizjournals.com
- St. Louis retailer Goedeker's closes acquisition, raises $205M in public offeringbizjournals.com
- HForest City closes public offering of Class A common stock at $22.50 per sharehome.crainscleveland.com
- KMicrobiome Therapeutics Market Growth Due to COVID-19 Spread | Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogicksusentinel.com
- Biologics startup to go public in reverse mergerbizjournals.com
- Heat Biologics looks to raise cash through public marketsbizjournals.com
- Eatery offering Indian buffet closesNewsday
- SandRidge closes $1.25 billion offeringjournalrecord.com
- AmerisourceBergen closes $1.5B debt offeringbizjournals.com
- Oneok plans public offeringjournalrecord.com